- In December 2008, ALLERGAN’s ® Latisse ® was approved by the U.S. Food and Drug Administration (FDA)
- Latisse ® was the first to certified by the USFDA to be officially approved as a eyelash growth prescription drug
- As the market’s one and only prescription eyelash growth formula, targeted to enhance eyelash length, density and darkness of eyelashes.
- Latisse ® is a product that satisfies current market needs. Apply once daily in the eyelash root to enhance eyelash prominence as measured increases in length, thickness and darkness of eyelashes.
Latisse Eyelash Solution Ingredient:
Bimatoprost ophthalmic solution 0.03%
Result: Increase the eyelash growth cycle
Features and Benefits:
Mainly targeted to enhance eyelash length, thickness and darkness
Clinically proven, apply once-daily to the base of the upper eyelashes, users can expect to experience an improvement of thickness and darkness of eyelashes in eight weeks, with best results in 12-16 weeks.